Ribosomal Incorporation of Intercalators into Peptides and Proteins in Living Organisms

At the University of Konstanz a novel method with very high selectivity has been developed, which allows the inclusion of amino acids with nucleic acid-intercalating properties into proteins and peptides. Protein- and peptide-based active pharmaceutical components often contain structures that act as intercalators. The technology uses standard protein expression methods and only requires the presence of the ncAA in the medium and the co-expression of the respective aminoacyl-tRNA synthetases as well as the tRNA. The invention has substantial potential for the development of new applications and products, in particular in the pharmaceutical and biotech fields.

Further information: PDF

Technologie-Lizenz-Büro (TLB) der Baden-Württembergischen Hochschulen GmbH
Phone: +49 (0)721/79 00 40

Contact
Dipl.-Biol. Marcus Lehnen, MBA

As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

High-energy-density aqueous battery based on halogen multi-electron transfer

Traditional non-aqueous lithium-ion batteries have a high energy density, but their safety is compromised due to the flammable organic electrolytes they utilize. Aqueous batteries use water as the solvent for…

First-ever combined heart pump and pig kidney transplant

…gives new hope to patient with terminal illness. Surgeons at NYU Langone Health performed the first-ever combined mechanical heart pump and gene-edited pig kidney transplant surgery in a 54-year-old woman…

Biophysics: Testing how well biomarkers work

LMU researchers have developed a method to determine how reliably target proteins can be labeled using super-resolution fluorescence microscopy. Modern microscopy techniques make it possible to examine the inner workings…

Partners & Sponsors